{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:22:54Z","timestamp":1790878974372,"version":"4.1.0"},"reference-count":225,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003500","name":"Universita degli Studi di Padova","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.autrev.2022.103037","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T03:35:12Z","timestamp":1641353712000},"page":"103037","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Myocarditis in systemic immune-mediated diseases: Prevalence, characteristics and prognosis. A systematic review"],"prefix":"10.1016","volume":"21","author":[{"given":"Chun-Yan","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Baritussio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Silvio","family":"Giordani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabino","family":"Iliceto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Marcolongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alida L.P.","family":"Caforio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2022.103037_bb0005","first-page":"295","article-title":"Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy","volume":"75","author":"K\u00fchl","year":"1996"},{"key":"10.1016\/j.autrev.2022.103037_bb0010","first-page":"455","article-title":"Immunohistologic evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy","volume":"39","author":"Mahon","year":"2002"},{"key":"10.1016\/j.autrev.2022.103037_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"10.1016\/j.autrev.2022.103037_bb0020","first-page":"840","article-title":"Diagnosis and management of sarcoidosis","volume":"93","author":"Soto-Gomez","year":"2016","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.autrev.2022.103037_bb0025","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2022.103037_bb0030","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/hrt.2004.045518","article-title":"Sudden adult death syndrome and other non-ischaemic causes of sudden cardiac death","volume":"92","author":"Fabre","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.autrev.2022.103037_bb0035","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1055\/s-0037-1602381","article-title":"Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment","volume":"38","author":"Sayah","year":"2017","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2022.103037_bb0040","first-page":"189","article-title":"Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis","volume":"85","author":"Tellier","year":"1988"},{"key":"10.1016\/j.autrev.2022.103037_bb0045","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1378\/chest.109.1.62","article-title":"Doppler echocardiographic detection of left ventricular diastolic dysfunction in patients with pulmonary sarcoidosis","volume":"109","author":"Fahy","year":"1996","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2022.103037_bb0050","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1378\/chest.72.1.27","article-title":"The use of 201thallium for myocardial perfusion imaging in sarcoid heart disease","volume":"72","author":"Bulkley","year":"1977","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2022.103037_bb0055","first-page":"478","article-title":"Two-dimensional echocardiographic findings in systemic sarcoidosis","volume":"63","author":"Burstow","year":"1989"},{"issue":"2018","key":"10.1016\/j.autrev.2022.103037_bb0060","first-page":"e91","volume":"72","author":"Al-Khatib","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2022.103037_bb0065","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.autrev.2022.103037_bb0070","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/eurjhf\/hfr099","article-title":"Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study","volume":"13","author":"Patel","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.autrev.2022.103037_bb0075","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcmg.2016.05.009","article-title":"Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis","volume":"10","author":"Coleman","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.autrev.2022.103037_bb0080","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1055\/s-0034-1376889","article-title":"Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment","volume":"35","author":"Lynch","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2022.103037_bb0085","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2169\/internalmedicine.52.8470","article-title":"Isolated primary cardiac sarcoidosis presenting as acute heart failure","volume":"52","author":"Sugizaki","year":"2013","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2022.103037_bb0090","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/01.md.0000145367.17934.75","article-title":"Cardiac sarcoidosis: a retrospective study of 41 cases","volume":"83","author":"Chapelon-Abric","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2022.103037_bb0095","article-title":"Zwei F\u00e4lle kardialer Sarkoidose als Ursache des pl\u00f6tzlichen Herztodes","author":"Schwarz","year":"2021","journal-title":"Rechtsmedizin"},{"key":"10.1016\/j.autrev.2022.103037_bb0100","first-page":"418","article-title":"Cardiac sarcoidosis masquerading as syncope with right ventricular septal mass","volume":"24","author":"Deshmukh","year":"2012","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.autrev.2022.103037_bb0105","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/j.1540-8167.2011.02114.x","article-title":"Arrhythmias in a patient with sarcoidosis","volume":"22","author":"Serra","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.autrev.2022.103037_bb0110","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jacc.2011.02.044","article-title":"Monomorphic ventricular tachycardia and mediastinal adenopathy due to granulomatous infiltration in patients with preserved ventricular function","volume":"58","author":"Thachil","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2022.103037_bb0115","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/CIRCEP.110.959254","article-title":"Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults","volume":"4","author":"Kandolin","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.autrev.2022.103037_bb0120","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1540-8167.2009.01479.x","article-title":"Sarcoid myocarditis with ventricular tachycardia mimicking ARVD\/C","volume":"21","author":"Ladyjanskaia","year":"2010","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.autrev.2022.103037_bb0125","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/17843286.2020.1724429","article-title":"Sarcoidosis presenting as cardiac tamponade: a case report","volume":"76","author":"Verdickt","year":"2021","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.autrev.2022.103037_bb0130","doi-asserted-by":"crossref","first-page":"546","DOI":"10.5114\/aoms.2011.24118","article-title":"Cardiac sarcoidosis: a comprehensive review","volume":"7","author":"Sekhri","year":"2011","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.autrev.2022.103037_bb0135","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.hrthm.2006.03.031","article-title":"Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation","volume":"3","author":"Koplan","year":"2006","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.autrev.2022.103037_bb0140","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1093\/eurheartj\/ehz428","article-title":"Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries","volume":"40","author":"Ekstrom","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.autrev.2022.103037_bb0145","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.amjcard.2021.04.039","article-title":"Long-Term Prognostic Significance of Ventricular Repolarization Dispersion in Patients with Cardiac Sarcoidosis","volume":"152","author":"Kobayashi","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.autrev.2022.103037_bb0150","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00005792-199903000-00001","article-title":"The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital","volume":"78","author":"Johns","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2022.103037_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106564","article-title":"The impact of demographic disparities in the presentation of sarcoidosis: A multicenter prospective study","volume":"187","author":"Zhou","year":"2021","journal-title":"Respir Med"},{"key":"10.1016\/j.autrev.2022.103037_bb0160","first-page":"e48","article-title":"Do clinical diagnoses correlate with pathological diagnoses in cardiac transplant patients? The importance of endomyocardial biopsy","volume":"25","author":"Luk","year":"2009"},{"key":"10.1016\/j.autrev.2022.103037_bb0165","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jchf.2014.03.015","article-title":"Electrogram guidance: a method to increase the precision and diagnostic yield of endomyocardial biopsy for suspected cardiac sarcoidosis and myocarditis","volume":"2","author":"Liang","year":"2014","journal-title":"JACC Heart Fail"},{"issue":"9","key":"10.1016\/j.autrev.2022.103037_bb0170","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1111\/jce.15191","article-title":"Electrogram-guided endomyocardial biopsy yield in patients with suspected cardiac sarcoidosis and relation to outcomes","volume":"32","author":"Ezzeddine","year":"2021","journal-title":"J Cardiovasc Electrophysiol."},{"key":"10.1016\/j.autrev.2022.103037_bb0175","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1097\/RLU.0000000000001669","article-title":"Initial experience with simultaneous 18F-FDG PET\/MRI in the evaluation of cardiac sarcoidosis and myocarditis","volume":"42","author":"Hanneman","year":"2017","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.autrev.2022.103037_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10112476","article-title":"Serum anti-heart and anti-intercalated disk autoantibodies: novel autoimmune markers in cardiac sarcoidosis","volume":"10","author":"Caforio","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2022.103037_bb0185","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","article-title":"Central Japan Heart Study, Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone","volume":"88","author":"Yazaki","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.autrev.2022.103037_bb0190","article-title":"Rituximab for the treatment of refractory cardiac sarcoidosis: a single-center experience","volume":"Jul 25","author":"Elwazir","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.autrev.2022.103037_bb0195","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1749-6632.1976.tb47058.x","article-title":"Clinicopathological study of fatal myocardial sarcoidosis","volume":"278","author":"Matsui","year":"1976","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2022.103037_bb0200","series-title":"Clinical Study on Cardiac Sarcoidosis","first-page":"530","volume":"465","author":"Tachibana","year":"1986"},{"key":"10.1016\/j.autrev.2022.103037_bb0205","series-title":"Sarcoidosis mortality in the United States, 1979\u20131991: an analysis of multiple-cause mortality data","first-page":"423","volume":"100","author":"Gideon","year":"1996"},{"key":"10.1016\/j.autrev.2022.103037_bb0210","first-page":"167","article-title":"Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations","volume":"119","author":"Perry","year":"1995","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.autrev.2022.103037_bb0215","first-page":"372","article-title":"Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan","volume":"43","author":"Iwai","year":"1993","journal-title":"Acta Pathol Jpn"},{"key":"10.1016\/j.autrev.2022.103037_bb0220","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7861\/clinmedicine.17-1-78","article-title":"Systemic lupus erythematosus","volume":"17","author":"Shaikh","year":"2017","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.autrev.2022.103037_bb0225","first-page":"iv8-13","article-title":"Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus","volume":"45 Suppl 4","author":"Tincani","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2022.103037_bb0230","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.autrev.2017.05.021","article-title":"Myocarditis in auto-immune or auto-inflammatory diseases","volume":"16","author":"Comarmond","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103037_bb0235","first-page":"9","article-title":"Heart disease in systemic lupus erythematosus: diagnosis and management","volume":"12","author":"Ansari","year":"1985","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.autrev.2022.103037_bb0240","first-page":"243","article-title":"The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy: a study of 36 necropsy patients","volume":"58","author":"Bulkley","year":"1975"},{"key":"10.1016\/j.autrev.2022.103037_bb0245","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s11845-018-1934-7","article-title":"Cardiac manifestations of Han Chinese patients with systemic lupus erythematosus: a retrospective study","volume":"188","author":"Jia","year":"2019","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.autrev.2022.103037_bb0250","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1177\/0961203318770018","article-title":"Lupus myocarditis: a single center experience and a comparative analysis of observational cohort studies","volume":"27","author":"Tanwani","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2022.103037_bb0255","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/rheumatology\/kem371","article-title":"Associated factors and impact of myocarditis in patients with SLE from LUMINA, a multiethnic US cohort (LV)","volume":"47","author":"Apte","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2022.103037_bb0260","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/0961203316651741","article-title":"Clinical features and outcome of lupus myocarditis in the Western Cape, South Africa","volume":"26","author":"Du Toit","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2022.103037_bb0265","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3899\/jrheum.160493","article-title":"Lupus Myocarditis: initial presentation and longterm outcomes in a multicentric series of 29 patients","volume":"44","author":"Thomas","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2022.103037_bb0270","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1177\/0961203318804889","article-title":"Child-onset systemic lupus erythematosus is associated with a higher incidence of myopericardial manifestations compared to adult-onset disease","volume":"27","author":"Chang","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2022.103037_bb0275","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1191\/0961203305lu2228oa","article-title":"Acute lupus myocarditis: clinical features and outcome of an oriental case series","volume":"14","author":"Law","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2022.103037_bb0280","doi-asserted-by":"crossref","first-page":"ytaa458","DOI":"10.1093\/ehjcr\/ytaa458","article-title":"Myocardial rupture and systemic lupus erythematosus: a case report","volume":"5","author":"Neto","year":"2021","journal-title":"Eur Heart J Case Rep"},{"key":"10.1016\/j.autrev.2022.103037_bb0285","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1177\/0961203314530486","article-title":"Myopericarditis with predominantly right ventricular involvement with normal B-type natriuretic peptide and cardiac tamponade as the initial manifestation of systemic lupus erythematosus","volume":"23","author":"Manautou","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2022.103037_bb0290","article-title":"Cardiogenic shock in autoimmune rheumatologic diseases: an insight on etiologies, management, and treatment outcomes","author":"Battisha","year":"2020","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.autrev.2022.103037_bb0295","series-title":"Myocarditis in systemic lupus erythematosus","first-page":"419","volume":"113","author":"Wijetunga","year":"2002"},{"key":"10.1016\/j.autrev.2022.103037_bb0300","first-page":"344","article-title":"Myocardial performance index in active and inactive paediatric systemic lupus erythematosus","volume":"35","author":"Khositseth","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2022.103037_bb0305","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1191\/0961203305lu2050oa","article-title":"Cardiac magnetic resonance imaging abnormalities in systemic lupus erythematosus: a preliminary report","volume":"14","author":"Singh","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2022.103037_bb0310","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2018-000265","article-title":"Myocarditis in systemic lupus erythematosus diagnosed by (18)F-fluorodeoxyglucose positron emission tomography","volume":"5","author":"Perel-Winkler","year":"2018","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.autrev.2022.103037_bb0315","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/acr.23720","article-title":"Clinical remission and low disease activity outcomes over 10 years in systemic lupus erythematosus","volume":"71","author":"Tselios","year":"2019","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2022.103037_bb0320","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2022.103037_bb0325","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.4103\/0366-6999.166029","article-title":"Lupus myocarditis: a case-control study from China","volume":"128","author":"Zhang","year":"2015","journal-title":"Chin Med J"},{"key":"10.1016\/j.autrev.2022.103037_bb0330","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1093\/eurheartj\/ehx321","article-title":"Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease","volume":"38","author":"Caforio","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.autrev.2022.103037_bb0335","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1177\/0961203310395800","article-title":"Acute lupus myocarditis: clinical features and outcome","volume":"20","author":"Appenzeller","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2022.103037_bb0340","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.autrev.2017.05.010","article-title":"Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 103 episodes in 89 adult patients","volume":"16","author":"Gavand","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103037_bb0345","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.amjcard.2007.03.054","article-title":"Comparison of survival among patients with connective tissue disease and cardiomyopathy (systemic sclerosis, systemic lupus erythematosus, and undifferentiated disease)","volume":"100","author":"Leyngold","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.autrev.2022.103037_bb0350","first-page":"1658","article-title":"Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry","volume":"31","author":"Buyon","year":"1998"},{"key":"10.1016\/j.autrev.2022.103037_bb0355","first-page":"191","article-title":"Results of lamellar keratoplasty for recurring pterygium (author\u2019s transl)","volume":"171","author":"Hallermann","year":"1977","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"10.1016\/j.autrev.2022.103037_bb0360","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jacc.2015.06.1088","article-title":"Serum biomarkers of inflammation, fibrosis, and cardiac function in facilitating diagnosis, prognosis, and treatment of Anti-SSA\/Ro-associated cardiac neonatal lupus","volume":"66","author":"Saxena","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2022.103037_bb0365","first-page":"796","article-title":"Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block","volume":"40","author":"Nield","year":"2002"},{"key":"10.1016\/j.autrev.2022.103037_bb0370","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/hc0702.104182","article-title":"Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis","volume":"105","author":"Nield","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2022.103037_bb0375","series-title":"Gynecology, Neonatal lupus erythematosus: results of maternal corticosteroid therapy","first-page":"952","volume":"93","author":"Shinohara","year":"1999"},{"key":"10.1016\/j.autrev.2022.103037_bb0380","first-page":"133","article-title":"A simplified understanding of the black swan: anti-phospholipid antibody syndrome","volume":"57","author":"Vaidya","year":"2019","journal-title":"JNMA J Nepal Med Assoc"},{"key":"10.1016\/j.autrev.2022.103037_bb0385","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1191\/0961203303lu391oa","article-title":"Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report","volume":"12","author":"Lockshin","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2022.103037_bb0390","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.rdc.2006.05.008","article-title":"Cardiac manifestations in the antiphospholipid syndrome","volume":"32","author":"Tenedios","year":"2006","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.autrev.2022.103037_bb0395","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.autrev.2006.06.007","article-title":"Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors","volume":"6","author":"Bucciarelli","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103037_bb0400","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Euro-phospholipid project, antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103037_bb0405","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1161\/CIRCULATIONAHA.113.007417","article-title":"Myocardial catastrophe: a case of sudden, severe myocardial dysfunction","volume":"130","author":"Hucker","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2022.103037_bb0410","first-page":"460","article-title":"A new postpartum syndrome associated with antiphospholipid antibodies","volume":"69","author":"Kochenour","year":"1987","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.autrev.2022.103037_bb0415","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1055\/s-2007-984406","article-title":"Myocarditis: an unusual cause of postpartum fever in pregnancy complicated by antiphospholipid syndrome","volume":"24","author":"Marnach","year":"2007","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.autrev.2022.103037_bb0420","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00380-014-0556-x","article-title":"Cardiac tamponade leading to the diagnosis of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): a case report and review of the literature","volume":"30","author":"Yano","year":"2015","journal-title":"Heart Vessel"},{"key":"10.1016\/j.autrev.2022.103037_bb0425","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3109\/14397595.2013.857582","article-title":"A nationwide survey on the epidemiology and clinical features of eosinophilic granulomatosis with polyangiitis (Churg-Strauss) in Japan","volume":"24","author":"Sada","year":"2014","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2022.103037_bb0430","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/BOR.0000000000000015","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): evolutions in classification, etiopathogenesis, assessment and management","volume":"26","author":"Mahr","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2022.103037_bb0435","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/01.md.0000180793.80212.17","volume":"84","author":"Bourgarit","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2022.103037_bb0440","article-title":"Eosinophilic myocarditis demonstrated using cardiac magnetic resonance imaging in a patient with eosinophilic granulomatosis with polyangiitis (Churg-Strauss Disease)","volume":"10","author":"Dalia","year":"2018","journal-title":"Cureus"},{"key":"10.1016\/j.autrev.2022.103037_bb0445","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005792-199901000-00003","article-title":"Clinical study and long-term follow-up of 96 patients","volume":"78","author":"Guillevin","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2022.103037_bb0450","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005080","article-title":"A case report and literature review of Churg-Strauss syndrome presenting with myocarditis","volume":"95","author":"Qiao","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2022.103037_bb0455","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1016\/j.jacc.2017.09.023","article-title":"Eosinophilic myocarditis: characteristics, treatment, and outcomes","volume":"70","author":"Brambatti","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2022.103037_bb0460","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/MD.0b013e3181af35a5","article-title":"Cardiac involvement in Churg-Strauss syndrome: impact of endomyocarditis","volume":"88","author":"Neumann","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2022.103037_bb0465","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/art.37721","article-title":"French Vasculitis Study, Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort","volume":"65","author":"Comarmond","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103037_bb0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.autrev.2016.09.018","volume":"16","author":"Cottin","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103037_bb0475","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-143-9-200511010-00006","article-title":"French Vasculitis Study, Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome","volume":"143","author":"Sable-Fourtassou","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2022.103037_bb0480","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/art.21250","article-title":"Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome","volume":"52","author":"Sinico","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103037_bb0485","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/acr2.11263","article-title":"Clinical manifestations and long-term outcomes of eosinophilic granulomatosis with polyangiitis in North America","volume":"3","author":"Doubelt","year":"2021","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.autrev.2022.103037_bb0490","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006083","article-title":"Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides: Impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity","volume":"96","author":"Solans-Laque","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"571\u20136","key":"10.1016\/j.autrev.2022.103037_bb0495","first-page":"e1","article-title":"Antineutrophil cytoplasmic autoantibodies and myeloperoxidase autoantibodies in clinical expression of Churg-Strauss syndrome","volume":"131","author":"Healy","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2022.103037_bb0500","first-page":"S41","article-title":"ANCA-positive and ANCA-negative phenotypes of eosinophilic granulomatosis with polyangiitis (EGPA): outcome and long-term follow-up of 50 patients from a single Polish center","volume":"32","author":"Sokolowska","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2022.103037_bb0505","article-title":"Rituximab and mepolizumab combination therapy for glucocorticoid-resistant myocarditis related to eosinophilic granulomatosis with polyangiitis","author":"Higashitani","year":"2021","journal-title":"Mod Rheumatol Case Rep"},{"key":"10.1016\/j.autrev.2022.103037_bb0510","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13075-021-02462-6","article-title":"Effectiveness and safety of mepolizumab in combination with corticosteroids in patients with eosinophilic granulomatosis with polyangiitis","volume":"23","author":"Ueno","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2022.103037_bb0515","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00005792-199601000-00003","article-title":"Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients","volume":"75","author":"Guillevin","year":"1996","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2022.103037_bb0520","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3904\/kjim.2014.29.1.85","article-title":"Clinical features and prognostic factors of Churg-Strauss syndrome","volume":"29","author":"Kim","year":"2014","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.autrev.2022.103037_bb0525","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2012-201531","article-title":"A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients","volume":"72","author":"Moosig","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103037_bb0530","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1161\/01.CIR.90.4.1855","article-title":"Long-term outcome for 120 Japanese patients with Takayasu\u2019s disease. Clinical and statistical analyses of related prognostic factors","volume":"90","author":"Ishikawa","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2022.103037_bb0535","series-title":"Book Patterns of symptoms and prognosis in occlusive thromboaortopathy (Takayasu's disease)","article-title":"Patterns of symptoms and prognosis in occlusive thromboaortopathy (Takayasu's disease)","author":"Ishikawa","year":"1986"},{"key":"10.1016\/j.autrev.2022.103037_bb0540","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/j.lpm.2017.05.034","article-title":"Epidemiology of Takayasu arteritis","volume":"46","author":"Onen","year":"2017","journal-title":"Presse Med"},{"key":"10.1016\/j.autrev.2022.103037_bb0545","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/ard.2004.022335","article-title":"Incidence of primary systemic vasculitides in Vilnius: a university hospital population based study","volume":"64","author":"Dadoniene","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103037_bb0550","first-page":"S40","article-title":"A population-based study of Takayasu s arteritis in eastern Denmark","volume":"29","author":"Dreyer","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2022.103037_bb0555","first-page":"299","article-title":"Takayasu's arteritis in Kuwait","volume":"98","author":"El-Reshaid","year":"1995","journal-title":"J Trop Med Hyg"},{"key":"10.1016\/j.autrev.2022.103037_bb0560","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/BF01744544","article-title":"Takayasu arteritis in Japan","volume":"7","author":"Koide","year":"1992","journal-title":"Heart Vessels Suppl"},{"key":"10.1016\/j.autrev.2022.103037_bb0565","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3899\/jrheum.140843","article-title":"Takayasu arteritis in southern Sweden","volume":"42","author":"Mohammad","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2022.103037_bb0570","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/rheumatology\/kep153","article-title":"The epidemiology of Takayasu arteritis in the UK","volume":"48","author":"Watts","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2022.103037_bb0575","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.semarthrit.2017.03.023","article-title":"A cohort study reveals myocarditis to be a rare and life-threatening presentation of large vessel vasculitis","volume":"47","author":"Bechman","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103037_bb0580","first-page":"S85","article-title":"An autopsy study of Takayasu arteritis in India","volume":"66","author":"Sharma","year":"1998"},{"key":"10.1016\/j.autrev.2022.103037_bb0585","first-page":"1666","article-title":"Cardiac involvement in nonspecific aortoarteritis (Takayasu's arteritis)","volume":"122","author":"Talwar","year":"1991"},{"key":"10.1016\/j.autrev.2022.103037_bb0590","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2169\/internalmedicine.44.256","article-title":"Takayasu myocarditis mediated by cytotoxic T lymphocytes","volume":"44","author":"Takeda","year":"2005","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2022.103037_bb0595","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1253\/circj.CJ-20-1218","article-title":"Pathological features of acute myocarditis associated with takayasu arteritis","volume":"85","author":"Kawano","year":"2021","journal-title":"Circ J"},{"key":"10.1016\/j.autrev.2022.103037_bb0600","doi-asserted-by":"crossref","DOI":"10.1097\/RHU.0000000000000957","article-title":"Silent myocarditis in Takayasu Arteritis","volume":"26","author":"Chattopadhyay","year":"2020","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.autrev.2022.103037_bb0605","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1093\/eurheartj\/ehv169","article-title":"Myocarditis associated with Takayasu arteritis","volume":"36","author":"Kotake","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.autrev.2022.103037_bb0610","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s002460010160","article-title":"Evidence for early vessel involvement in the dysfunctional myocardium of Takayasu\u2019s arteritis","volume":"22","author":"Breinholt","year":"2001","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.autrev.2022.103037_bb0615","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/0002-8703(91)90285-P","article-title":"Cardiac involvement in nonspecific aortoarteritis (Takayasu\u2019s arteritis)","volume":"122","author":"Talwar","year":"1991","journal-title":"Am Heart J"},{"key":"10.1016\/j.autrev.2022.103037_bb0620","doi-asserted-by":"crossref","first-page":"iii6","DOI":"10.1093\/rheumatology\/keab036","article-title":"A rare life-threatening presentation of Takayasu arteritis","volume":"60","author":"Porter","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2022.103037_bb0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.carpath.2021.107347","article-title":"Atypical presentation of Takayasu aortitis and myocarditis contributing to sudden death in a young Canadian first nations adult","volume":"54","author":"Ferreira","year":"2021","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.autrev.2022.103037_bb0630","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0167-5273(88)90109-X","article-title":"Myocardial involvement and its response to immunosuppressive therapy in nonspecific aortoarteritis (Takayasu\u2019s disease)--a study by endomyocardial biopsy","volume":"21","author":"Talwar","year":"1988","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2022.103037_bb0635","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1002\/art.24911","article-title":"Integrated cardiac and vascular assessment in Takayasu arteritis by cardiovascular magnetic resonance","volume":"60","author":"Keenan","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103037_bb0640","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.amjcard.2013.11.045","article-title":"Findings of cardiac magnetic resonance imaging in asymptomatic myocardial ischemic disease in Takayasu arteritis","volume":"113","author":"Comarmond","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.autrev.2022.103037_bb0645","first-page":"318","article-title":"EULAR recommendations for the management of large vessel vasculitis","volume":"68","author":"Mukhtyar","year":"2009"},{"key":"10.1016\/j.autrev.2022.103037_bb0650","first-page":"323","article-title":"Myocardial involvement and its response to immunosuppressive therapy in nonspecific aortoarteritis (Takayasu's disease)\u2014a study by endomyocardial biopsy","volume":"21","author":"Talwar","year":"1988"},{"key":"10.1016\/j.autrev.2022.103037_bb0655","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-200203000-00004","article-title":"Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients","volume":"81","author":"Ferri","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2022.103037_bb0660","first-page":"997","article-title":"Severe myositis and myocarditis in progressive systemic sclerosis","volume":"12","author":"Carette","year":"1985","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2022.103037_bb0665","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1378\/chest.101.3.872","article-title":"Acute myocarditis in fulminant systemic sclerosis","volume":"101","author":"Clemson","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2022.103037_bb0670","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/clc.4960161212","article-title":"Myocarditis as a complication in scleroderma patients with myositis","volume":"16","author":"Kerr","year":"1993","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.autrev.2022.103037_bb0675","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/rheumatology\/39.6.674","article-title":"The possible role of myocardial biopsy in systemic sclerosis","volume":"39","author":"Liangos","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2022.103037_bb0680","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.semarthrit.2013.07.006","article-title":"Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression","volume":"43","author":"Pieroni","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103037_bb0685","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103037_bb0690","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.semarthrit.2017.03.020","article-title":"Cardiovascular magnetic resonance in systemic sclerosis: \"Pearls and pitfalls\"","volume":"47","author":"Mavrogeni","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103037_bb0695","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1532-429X-16-21","article-title":"Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis--a clinical study using myocardial T1-mapping and extracellular volume quantification","volume":"16","author":"Ntusi","year":"2014","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.autrev.2022.103037_bb0700","article-title":"Cardiovascular magnetic resonance identifies high-risk systemic sclerosis patients with normal echocardiograms and provides incremental prognostic value","volume":"9","author":"Markousis-Mavrogenis","year":"2019","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.autrev.2022.103037_bb0705","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12872-017-0619-x","article-title":"Silent myocarditis in systemic sclerosis detected by cardiovascular magnetic resonance using Lake Louise criteria","volume":"17","author":"Mavrogeni","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.autrev.2022.103037_bb0710","doi-asserted-by":"crossref","first-page":"661","DOI":"10.7326\/0003-4819-105-5-661","article-title":"Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis","volume":"105","author":"Alexander","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2022.103037_bb0715","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.CIR.53.3.483","article-title":"Myocardial lesions of progressive systemic sclerosis, A cause of cardiac dysfunction","volume":"53","author":"Bulkley","year":"1976","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2022.103037_bb0720","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1136\/ard.2008.095836","article-title":"Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients","volume":"68","author":"Hachulla","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103037_bb0725","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1002\/art.22971","article-title":"Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study","volume":"56","author":"Tzelepis","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103037_bb0730","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5301\/jsrd.5000231","article-title":"Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis","volume":"2","author":"Khanna","year":"2017","journal-title":"J Scleroderma Relat Disord"},{"key":"10.1016\/j.autrev.2022.103037_bb0735","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1093\/rheumatology\/kez658","article-title":"Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysis","volume":"59","author":"De Luca","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2022.103037_bb0740","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ehf2.12139","article-title":"Autoimmune myocarditis in systemic sclerosis: an unusual form of scleroderma heart disease presentation","volume":"4","author":"Ramalho","year":"2017","journal-title":"ESC Heart Fail"},{"issue":"11","key":"10.1016\/j.autrev.2022.103037_bb0745","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.3390\/diagnostics11112165","article-title":"Serum organ-specific anti-heart and anti-intercalated disk autoantibodies as new autoimmune markers of cardiac involvement in systemic sclerosis: frequency, clinical and prognostic correlates","volume":"11","author":"Caforio","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.autrev.2022.103037_bb0750","first-page":"431","article-title":"Glucocorticoid effects on myocardial performance in patients with systemic sclerosis","volume":"19","author":"Antoniades","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2022.103037_bb0755","doi-asserted-by":"crossref","first-page":"8884442","DOI":"10.1155\/2020\/8884442","article-title":"Clinical outcomes of myocarditis after moderate-dose steroid therapy in systemic sclerosis: a pilot study","volume":"2020","author":"Pussadhamma","year":"2020","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.autrev.2022.103037_bb0760","article-title":"Cardiac involvement in systemic sclerosis: Getting to the heart of the matter","volume":"101668","author":"Bruni","year":"2021","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2022.103037_bb0765","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1093\/rheumatology\/keaa193","article-title":"Rituximab for rapidly progressive juvenile systemic sclerosis","volume":"59","author":"Zulian","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2022.103037_bb0770","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3748\/wjg.v22.i3.917","article-title":"Inflammatory bowel disease imaging: Current practice and future directions","volume":"22","author":"Kilcoyne","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2022.103037_bb0775","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00408-010-9259-y","article-title":"Pleuropericarditis in a patient with inflammatory bowel disease: a case presentation and review of the literature","volume":"188","author":"Abu-Hijleh","year":"2010","journal-title":"Lung"},{"issue":"11_Supplement_1","key":"10.1016\/j.autrev.2022.103037_bb0780","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0735-1097(20)31704-6","article-title":"Myocarditis complicating inflammatory bowel disease: a comparison between ulcerative colitis and crohn's disease from the national inpatient sample","volume":"75","author":"Patil","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2022.103037_bb0785","first-page":"442","article-title":"Myocarditis and inflammatory bowel disease. A 16-year Danish nationwide cohort study","volume":"44","author":"Sorensen","year":"1997","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.autrev.2022.103037_bb0790","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1093\/ibd\/izy157","article-title":"Heart under attack: cardiac manifestations of inflammatory Bowel disease","volume":"24","author":"Mitchell","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2022.103037_bb0795","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.revmed.2012.07.015","article-title":"Acute myocarditis and inflammatory bowel diseases: a case series of two patients","volume":"33","author":"Le Mener","year":"2012","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.autrev.2022.103037_bb0800","doi-asserted-by":"crossref","first-page":"512","DOI":"10.5009\/gnl.2012.6.4.512","article-title":"A case of acute myocarditis as the initial presentation of Crohn\u2019s disease","volume":"6","author":"Oh","year":"2012","journal-title":"Gut Liver"},{"key":"10.1016\/j.autrev.2022.103037_bb0805","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/2047-783X-19-11","article-title":"Recurrent lymphocytic myocarditis in a young male with ulcerative colitis","volume":"19","author":"Varnavas","year":"2014","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.autrev.2022.103037_bb0810","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1136\/emj.2007.054643","article-title":"Fulminant myocarditis: a rare but life-threatening association of Crohn\u2019s disease","volume":"25","author":"Nishtar","year":"2008","journal-title":"Emerg Med J"},{"key":"10.1016\/j.autrev.2022.103037_bb0815","first-page":"390","article-title":"Pericarditis in exacerbation of ulcerative colitis","volume":"69","author":"Virovic Jukic","year":"2006","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.autrev.2022.103037_bb0820","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1097\/00042737-200110000-00022","article-title":"Cardiomyopathy and pericardial tamponade in ulcerative colitis","volume":"13","author":"Dubowitz","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2022.103037_bb0825","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.3748\/wjg.v21.i11.3376","article-title":"Proposed case of mesalazine-induced cardiomyopathy in severe ulcerative colitis","volume":"21","author":"Fleming","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2022.103037_bb0830","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-3-319-57613-8_10","article-title":"Cardiac autoimmunity: myocarditis","volume":"1003","author":"Bracamonte-Baran","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.autrev.2022.103037_bb0835","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1155\/2001\/954340","article-title":"Giant cell myocarditis, in a patient with Crohn\u2019s disease, treated with etanercept--a tumour necrosis factor-alpha antagonist","volume":"15","author":"Nash","year":"2001","journal-title":"Can J Gastroenterol"},{"issue":"2636-48","key":"10.1016\/j.autrev.2022.103037_bb0840","volume":"34","author":"Caforio","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.autrev.2022.103037_bb0845","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4212\/cjhp.v69i6.1610","article-title":"5-Aminosalicylic Acid-Associated Myocarditis and Pericarditis: A Narrative Review","volume":"69","author":"Brown","year":"2016","journal-title":"Can J Hosp Pharm"},{"key":"10.1016\/j.autrev.2022.103037_bb0850","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1046\/j.1365-2036.1996.92264000.x","article-title":"Adverse events in patients treated with 5-aminosalicyclic acid: 1993-1994 pharmacovigilance report for Pentasa in France","volume":"10","author":"Marteau","year":"1996","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.autrev.2022.103037_bb0855","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.ejim.2014.11.001","article-title":"Rate and patient features associated with recurrence of acute myocarditis","volume":"25","author":"Kyto","year":"2014","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.autrev.2022.103037_bb0860","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1093\/eurheartj\/ehr165","article-title":"The management of myocarditis","volume":"32","author":"Schultheiss","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.autrev.2022.103037_bb0865","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijcard.2010.08.013","article-title":"Clinical cardiac involvement in idiopathic inflammatory myopathies: a systematic review","volume":"148","author":"Gupta","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2022.103037_bb0870","first-page":"686","article-title":"Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review","volume":"35","author":"Zhang","year":"2012","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.autrev.2022.103037_bb0875","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/art.1780221007","article-title":"Cardiac involvement in polymyositis: a clinicopathologic study of 20 autopsied patients","volume":"22","author":"Denbow","year":"1979","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103037_bb0880","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00415-014-7623-1","article-title":"Early diagnosis of cardiac involvement in idiopathic inflammatory myopathy by cardiac magnetic resonance tomography","volume":"262","author":"Rosenbohm","year":"2015","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2022.103037_bb0885","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.ijcard.2012.09.109","article-title":"Myocarditis during acute inflammatory myopathies: evaluation using clinical criteria and cardiac magnetic resonance imaging","volume":"164","author":"Mavrogeni","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2022.103037_bb0890","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019415","article-title":"Manifestations and outcome of cardiac sarcoidosis and idiopathic giant cell myocarditis by 25-year nationwide cohorts","volume":"10","author":"Nordenswan","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.autrev.2022.103037_bb0895","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01160-2020","article-title":"Clinical phenotypes of extrapulmonary sarcoidosis: an analysis of a French, multi-ethnic, multicentre cohort","volume":"57","author":"Lhote","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.autrev.2022.103037_bb0900","first-page":"104","article-title":"Sarcoidosis and increased risk of comorbidities and mortality in sweden","volume":"37","author":"Larsson","year":"2020","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.autrev.2022.103037_bb0905","first-page":"24","article-title":"The incidence, comorbidity and mortality of sarcoidosis in Korea, 2008-2015: a nationwide population-based study","volume":"37","author":"Jeon","year":"2020","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.autrev.2022.103037_bb0910","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238391","article-title":"Cardiac sarcoidosis: A long term follow up study","volume":"15","author":"Cacoub","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2022.103037_bb0915","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jacc.2020.06.038","article-title":"Long-term adverse cardiac outcomes in patients with sarcoidosis","volume":"76","author":"Yafasova","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2022.103037_bb0920","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12890-020-01191-x","article-title":"Clinical characteristics and organ system involvement in sarcoidosis: comparison of the University of Minnesota Cohort with other cohorts","volume":"20","author":"Te","year":"2020","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.autrev.2022.103037_bb0925","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1007\/s00330-020-06765-1","article-title":"Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis","volume":"30","author":"Flamee","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.autrev.2022.103037_bb0930","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.resinv.2019.11.003","article-title":"Characteristics of 68 patients with clinically proven sarcoidosis based on the Japan Society of Sarcoidosis and Other Granulomatous Disorders 2015 criteria","volume":"58","author":"Yamanouchi","year":"2020","journal-title":"Respir Investig"},{"key":"10.1016\/j.autrev.2022.103037_bb0935","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2019.01.001","article-title":"Can the Sarcoidosis Health Questionnaire predict the long-term outcomes in Japanese sarcoidosis patients?","volume":"149","author":"Tanizawa","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.autrev.2022.103037_bb0940","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1177\/1925362118797744","article-title":"Cardiac involvement in sarcoidosis deaths in Wayne County, Michigan: A 20-year retrospective Study","volume":"8","author":"Webb","year":"2018","journal-title":"Acad Forensic Pathol"},{"key":"10.1016\/j.autrev.2022.103037_bb0945","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00991-2017","article-title":"Phenotypes of organ involvement in sarcoidosis","volume":"51","author":"Schupp","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.autrev.2022.103037_bb0950","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijcard.2017.09.204","article-title":"How common is isolated cardiac sarcoidosis? Extra-cardiac and cardiac findings on clinical examination and whole-body (18)F-fluorodeoxyglucose positron emission tomography","volume":"253","author":"Juneau","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2022.103037_bb0955","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.chest.2017.10.014","article-title":"Clinical course of sarcoidosis in world trade center-exposed firefighters","volume":"153","author":"Hena","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2022.103037_bb0960","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00408-017-0037-y","article-title":"Clinical and biological insights from the university of California San Francisco prospective and longitudinal Cohort","volume":"195","author":"Benn","year":"2017","journal-title":"Lung"},{"key":"10.1016\/j.autrev.2022.103037_bb0965","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijcard.2016.08.298","article-title":"Cardiac involvement in patients with rheumatic disorders: Data of the RHEU-M(A)R study","volume":"224","author":"Greulich","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2022.103037_bb0970","first-page":"275","article-title":"Causes of death in patients with chronic sarcoidosis","volume":"33","author":"Hu","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.autrev.2022.103037_bb0975","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.chest.2016.08.1457","article-title":"Cardiac sarcoidosis: the impact of age and implanted devices on survival","volume":"151","author":"Zhou","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2022.103037_bb0980","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004518","article-title":"Prevalence of cardiac sarcoidosis in white population: a case-control study: Proposal for a novel risk index based on commonly available tests","volume":"95","author":"Martusewicz-Boros","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2022.103037_bb0985","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00408-015-9805-8","article-title":"Cardiac sarcoidosis: is it more common in men?","volume":"194","author":"Martusewicz-Boros","year":"2016","journal-title":"Lung"},{"key":"10.1016\/j.autrev.2022.103037_bb0990","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2015.03.175","article-title":"Electrocardiographic abnormalities and risk of developing cardiac events in extracardiac sarcoidosis","volume":"189","author":"Nagao","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2022.103037_bb0995","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1253\/circj.CJ-14-1275","article-title":"Effect of corticosteroid therapy on long-term clinical outcome and left ventricular function in patients with cardiac sarcoidosis","volume":"79","author":"Nagai","year":"2015","journal-title":"Circ J"},{"key":"10.1016\/j.autrev.2022.103037_bb1000","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.rmed.2014.12.012","article-title":"Age-related and historical changes in the clinical characteristics of sarcoidosis in Japan","volume":"109","author":"Sawahata","year":"2015","journal-title":"Respir Med"},{"key":"10.1016\/j.autrev.2022.103037_bb1005","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1378\/chest.14-0139","article-title":"Incidence and prognostic significance of myocardial late gadolinium enhancement in patients with sarcoidosis without cardiac manifestation","volume":"146","author":"Nagai","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2022.103037_bb1010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1465-9921-15-15","article-title":"Cardiac involvement in Caucasian patients with pulmonary sarcoidosis","volume":"15","author":"Darlington","year":"2014","journal-title":"Respir Res"},{"key":"10.1016\/j.autrev.2022.103037_bb1015","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10384-013-0288-y","article-title":"Prediction of severe cardiac involvement by fundus lesion in sarcoidosis","volume":"58","author":"Umazume","year":"2014","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.autrev.2022.103037_bb1020","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/acr.22181","article-title":"Cardiac tissue characterization and the diagnostic value of cardiovascular magnetic resonance in systemic connective tissue diseases","volume":"66","author":"Mavrogeni","year":"2014","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2022.103037_bb1025","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/j.1540-8167.2011.02099.x","article-title":"Electrocardiographic characteristics in patients with pulmonary sarcoidosis indicating cardiac involvement","volume":"22","author":"Schuller","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.autrev.2022.103037_bb1030","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","article-title":"Detection of myocardial damage in patients with sarcoidosis","volume":"120","author":"Patel","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2022.103037_bb1035","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.amjcard.2009.03.068","article-title":"Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes","volume":"104","author":"Tavora","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.autrev.2022.103037_bb1040","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1378\/chest.07-2784","article-title":"Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing","volume":"133","author":"Mehta","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2022.103037_bb1045","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1183\/09031936.00075307","article-title":"Epidemiology of sarcoidosis in Japan","volume":"31","author":"Morimoto","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.autrev.2022.103037_bb1050","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1378\/chest.128.1.30","article-title":"Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands","volume":"128","author":"Smedema","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2022.103037_bb1055","first-page":"220","article-title":"Sarcoidosis in northern Israel; clinical characteristics of 120 patients","volume":"19","author":"Yigla","year":"2002","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.autrev.2022.103037_bb1060","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2022.103037_bb1065","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0002-8703(97)70070-X","article-title":"Incidence of cardiac sarcoidosis in Japanese patients with high-degree atrioventricular block","volume":"134","author":"Yoshida","year":"1997","journal-title":"Am Heart J"},{"key":"10.1016\/j.autrev.2022.103037_bb1070","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0002-9343(97)89518-6","article-title":"Sarcoidosis mortality in the United States 1979-1991: an analysis of multiple-cause mortality data","volume":"100","author":"Gideon","year":"1996","journal-title":"Am J Med"},{"issue":"Suppl D","key":"10.1016\/j.autrev.2022.103037_bb1075","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/eurheartj\/12.suppl_D.26","article-title":"Sarcoid heart disease--results of follow-up investigations","volume":"12","author":"Schaedel","year":"1991","journal-title":"Eur Heart J"},{"key":"10.1016\/j.autrev.2022.103037_bb1080","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2022.103037_bb1085","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/art.27263","article-title":"Cardiac involvement in Churg-Strauss syndrome","volume":"62","author":"Dennert","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103037_bb1090","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/acr.22686","article-title":"Long-term followup of a multicenter Cohort of 101 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss)","volume":"68","author":"Durel","year":"2016","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2022.103037_bb1095","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijcard.2015.06.087","article-title":"Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis","volume":"199","author":"Hazebroek","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2022.103037_bb1100","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00259-010-1617-8","article-title":"123I-MIBG imaging detects cardiac involvement and predicts cardiac events in Churg-Strauss syndrome","volume":"38","author":"Horiguchi","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.autrev.2022.103037_bb1105","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/rheumatology\/kes155","article-title":"Churg-Strauss syndrome cardiac involvement evaluated by cardiac magnetic resonance imaging and positron-emission tomography: a prospective study on 20 patients","volume":"52","author":"Marmursztejn","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2022.103037_bb1110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/qjmed\/91.3.219","article-title":"Churg-Strauss syndrome in a district hospital","volume":"91","author":"Reid","year":"1998","journal-title":"QJM"},{"key":"10.1016\/j.autrev.2022.103037_bb1115","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.3899\/jrheum.161436","article-title":"Longterm prognosis of 121 patients with eosinophilic granulomatosis with polyangiitis in Japan","volume":"44","author":"Tsurikisawa","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2022.103037_bb1120","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejim.2020.12.008","article-title":"Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre","volume":"85","author":"Zampieri","year":"2021","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.autrev.2022.103037_bb1125","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0002-9343(03)00359-0","article-title":"Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists","volume":"115","author":"Keogh","year":"2003","journal-title":"Am J Med"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222000076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222000076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:24:54Z","timestamp":1761600294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997222000076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":225,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1568997222000076"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103037","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myocarditis in systemic immune-mediated diseases: Prevalence, characteristics and prognosis. A systematic review","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103037"}}